On this page
If you’re breastfeeding, the cautious answer is to wait until you’ve stopped. Two small studies found little or no semaglutide or tirzepatide in breast milk, but no one has followed nursing babies through months of exposure. If you’re formula feeding, the timing depends on your recovery, and your clinician will talk it through with you. Either way, you usually restart at the lowest starting dose, even if you were on a higher one before pregnancy.
If you’re breastfeeding
Here is what the evidence actually contains.
- Tirzepatide: the Zepbound label now includes a single-dose study in 11 lactating women given 5 mg. Tirzepatide was undetectable in 164 of 171 milk samples, and the total amount found was under 0.02% of the mother’s dose. The label also says there are no data on effects on the breastfed infant or on milk supply.
- Semaglutide: the Wegovy label has no human milk data, only that semaglutide was found in the milk of lactating rats. Outside the label, Diab and colleagues (Nutrients, 2024) tested milk from 8 women on injected semaglutide at 0.25–1 mg weekly and found none at any time point.
That is reassuring about how much drug reaches the milk. It says nothing yet about the higher maintenance doses, about months of daily exposure for a baby, or about whether appetite suppression and weight loss affect milk supply. Both labels leave nursing as a weighing of your need for the drug against an unmeasured risk to the baby, and neither calls it safe.
Our position is to wait. The weight can wait a few months; the baby’s exposure can’t be undone. A larger study with infant follow-up and milk-supply data would change that view. Compounded semaglutide and tirzepatide are not FDA-approved and have no labels, so none of the label data above applies to them directly.
If you still want to start while nursing, bring it to your OB and your baby’s pediatrician first. The decision involves the baby, so both should weigh in.
When you can start if you’re not nursing
No drug label and no ACOG guideline gives a GLP-1 start date after delivery. So there’s no set window. Your clinician looks at how you’re healing, how you’re eating, and your plans for another pregnancy. ACOG advises a full postpartum visit by 12 weeks, which makes that visit a natural checkpoint.
- C-section: tell your clinician how you delivered. The first weeks of a GLP-1 bring nausea and lower intake, and that lands harder while an incision is still healing.
- Weaning: wait until you’ve fully stopped nursing and pumping.
- Combination feeding: any breastfeeding counts as breastfeeding here.
If you might want another pregnancy soon, say so before you start. The Wegovy label says to stop semaglutide at least 2 months before a planned pregnancy, because it takes weeks to clear the body. GLP-1s are not for use in pregnancy.
Restart at the lowest dose
Your clinician will usually restart you at the lowest starting dose, whatever you took before. On the labels, that’s 0.25 mg weekly for the Wegovy injection and 2.5 mg weekly for Zepbound. The daily Wegovy pill has its own starting dose on its label. The stomach-slowing effect behind the nausea is strongest early and fades as you adapt; after months off the drug, that adaptation is gone. Going straight back to an old dose would be like skipping several titration steps at once, with the nausea, reflux, and fullness that follow.
From there, the labels step the dose up about every 4 weeks, more slowly if side effects hit. The screening is the same as before pregnancy: no GLP-1 if you have MEN 2 or if you or a family member has had medullary thyroid cancer, and extra caution after pancreatitis. The full list is on the GLP-1 safety page.
Why PCOS or gestational diabetes changes the timing
Pregnancy raises insulin resistance, largely through placental hormones, which keeps more glucose available for the baby. For most people that fades after delivery. If you went into pregnancy with PCOS or insulin resistance, or developed gestational diabetes, you come out of it with the underlying problem still there. That argues for getting labs done and having a plan ready, rather than putting treatment off indefinitely. It doesn’t shorten the breastfeeding wait or the healing window. How GLP-1s act on insulin resistance is covered in GLP-1 and PCOS.
What to do while you wait
- Walk daily. Start short and build up as your OB allows. After a C-section, follow your surgeon’s lifting limits.
- Put protein first at meals. Once a GLP-1 cuts your appetite, protein plus strength training is the main defense against losing muscle along with fat, and the habit is easier to build now.
- Ask about postpartum labs. Your clinician or OB may suggest tests based on your pregnancy and how you feel. These can include thyroid, since postpartum thyroid problems can look like fatigue or weight change; iron, after blood loss at delivery; and glucose. If you had gestational diabetes, the ADA recommends a glucose tolerance test at 4–12 weeks postpartum.
Have contraception in place before you start
Ovulation can come back before your first postpartum period, and weight loss can bring it back sooner, especially with PCOS. Tirzepatide can also lower the absorption of birth control pills. The Zepbound label advises switching to a non-oral method, or adding a barrier method, for 4 weeks after you start and 4 weeks after each dose increase. An IUD or implant avoids the issue. The details are in GLP-1, birth control, and PCOS.
When to call your clinician
- You get a positive pregnancy test. Stop the medication and call.
- You have severe belly pain, especially pain that spreads to your back or sits under your right ribs.
- You’re vomiting and can’t keep fluids down.
- You decide to breastfeed again or try relactation.
- Your mood drops, or you can’t eat enough to stay on your feet. Your OB needs to hear about this whether or not you’re on a GLP-1.
Your next step
Tell your clinician how you’re feeding your baby, how you delivered, and when your postpartum visit was. Those three facts shape the timing. If you’re formula feeding and ready to talk about timing, see semaglutide or tirzepatide for how Zappy’s plans work. A clinician reviews every intake.
